Carboxymethylcellulose
Carboxymethylcellulose is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| eye diseases | D005128 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| acne patchs | unapproved drug other | 2021-01-06 |
| auro-cmc | C200263 | 2025-03-17 |
| biolle gel tears | OTC monograph final | 2016-04-13 |
| biolle tears | OTC monograph final | 2016-03-25 |
| carboxymethylcellulose sodium | C200263 | 2025-11-11 |
| carboxymethylcellulose sodium 0.5% | C200263 | 2025-02-25 |
| carboxymethylcellulose sodium eye drops 0.5% | C200263 | 2025-04-12 |
| carboxymethylcellulose sodium eye lubricant | C200263 | 2024-11-07 |
| cvs lubricant eye | OTC monograph final | 2017-11-27 |
| cvs lubricant eye drops | C200263 | 2023-12-23 |
Show 91 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
232 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dry eye syndromes | D015352 | — | H04.12 | 1 | 4 | 9 | 18 | 18 | 48 |
| Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | 1 | 3 | 8 | 11 | 12 | 34 |
| Eye diseases | D005128 | EFO_0003966 | H44 | 1 | 1 | 2 | 2 | 3 | 9 |
| Ulcer | D014456 | MPATH_579 | — | 2 | 1 | 2 | 2 | 2 | 8 |
| Syndrome | D013577 | — | — | 2 | — | 1 | 2 | 2 | 7 |
| Prostatic neoplasms | D011471 | — | C61 | 2 | 1 | — | 2 | — | 5 |
| Wounds and injuries | D014947 | — | T14.8 | — | 1 | 1 | 1 | 3 | 5 |
| Tissue adhesions | D000267 | — | — | — | — | — | 3 | 1 | 4 |
| Hepatitis | D006505 | — | K75.9 | 1 | 1 | — | 1 | — | 3 |
| Hepatitis a | D006506 | EFO_0007305 | B15 | 1 | 1 | — | 1 | — | 3 |
Show 47 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leg ulcer | D007871 | — | — | — | — | 2 | — | 2 | 4 |
| Varicose ulcer | D014647 | — | — | — | — | 1 | — | 3 | 4 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | 1 | 2 | — | — | 3 |
| Recurrence | D012008 | — | — | 2 | 1 | 1 | — | — | 3 |
| Covid-19 | D000086382 | — | U07.1 | — | 1 | 3 | — | — | 3 |
| Sclerosis | D012598 | — | — | 1 | 2 | 1 | — | — | 3 |
| Conjunctivitis | D003231 | — | H10 | — | 2 | 1 | — | 1 | 3 |
| Infections | D007239 | EFO_0000544 | — | — | — | 1 | — | 1 | 2 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | 1 | 1 | — | — | 2 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | 1 | 1 | — | — | 2 |
Show 15 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Breast neoplasms | D001943 | EFO_0003869 | C50 | 3 | 2 | — | — | — | 5 |
| Melanoma | D008545 | — | — | 4 | 2 | — | — | — | 5 |
| Carcinoma | D002277 | — | C80.0 | 4 | 2 | — | — | — | 4 |
| Glioblastoma | D005909 | EFO_0000515 | — | 2 | 1 | — | — | 1 | 3 |
| Neoplasms | D009369 | — | C80 | 3 | 2 | — | — | — | 3 |
| Non-small-cell lung carcinoma | D002289 | — | — | 3 | 1 | — | — | — | 3 |
| Colorectal neoplasms | D015179 | — | — | 1 | 1 | — | — | — | 2 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 2 | — | — | — | 2 |
| Fallopian tube neoplasms | D005185 | — | — | 2 | 2 | — | — | — | 2 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | — | — | 1 | 2 |
Show 36 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 6 | — | — | — | 3 | 9 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 3 | — | — | — | — | 3 |
| Anemia | D000740 | EFO_0004272 | D64.9 | 2 | — | — | — | 1 | 3 |
| Leukemia | D007938 | — | C95 | 2 | — | — | — | — | 2 |
| Myelodysplastic syndromes | D009190 | — | D46 | 2 | — | — | — | — | 2 |
| Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 2 | — | — | — | — | 2 |
| Myeloid leukemia | D007951 | — | C92 | 2 | — | — | — | — | 2 |
| Myelomonocytic leukemia juvenile | D054429 | — | C93.3 | 2 | — | — | — | — | 2 |
| Preleukemia | D011289 | — | — | 2 | — | — | — | — | 2 |
| Refractory anemia | D000753 | — | D46.4 | 2 | — | — | — | — | 2 |
Show 27 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 4 | 4 |
| Overweight | D050177 | — | E66.3 | — | — | — | — | 3 | 3 |
| Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | — | — | — | — | 2 | 2 |
| Corneal diseases | D003316 | — | H18.9 | — | — | — | — | 2 | 2 |
| Xerostomia | D014987 | — | K11.7 | — | — | — | — | 2 | 2 |
| Hypoglycemia | D007003 | — | E16.2 | — | — | — | — | 1 | 1 |
| Essential tremor | D020329 | EFO_0003108 | G25.0 | — | — | — | — | 1 | 1 |
| Pterygium | D011625 | — | H11.0 | — | — | — | — | 1 | 1 |
| Headache | D006261 | — | R51 | — | — | — | — | 1 | 1 |
| Post-dural puncture headache | D051299 | — | — | — | — | — | — | 1 | 1 |
Show 60 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Carboxymethylcellulose |
| INN | carmellose |
| Description | Carboxymethyl cellulose (CMC) or cellulose gum is a cellulose derivative with carboxymethyl groups (-CH2-COOH) bound to some of the hydroxyl groups of the glucopyranose monomers that make up the cellulose backbone. It is often used as its sodium salt, sodium carboxymethyl cellulose. It used to be marketed under the name Tylose, a registered trademark of SE Tylose.
|
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | CHEMBL1909054 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | 05JZI7B19X (ChemIDplus, GSRS) |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 42,140 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
7,669 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use